Blood biomarkers of Alzheimers disease: findings from proteomics
For instance, a study on ME/CFS demonstrated the efficacy of the tricarboxylic acid (TCA) cycle metabolite oxaloacetate in improving symptoms (Cash and Kaufman, 2023), patients showed marked improvements in fatigue scores as measured by the Chalder Fatigue Questionnaire in a randomized, double-blind, placebo-controlled trial using AXA1125
When these levels drop, the bodys "bucket" of antioxidant protection begins to overflow
The peptide is establishing its metabolic effects on fat tissue, but the total amount of fat oxidized over just 7-14 days is insufficient to produce measurable body composition changes
These monotherapy results established proof of concept that amylin receptor agonism alone can produce clinically meaningful weight reduction and informed the dose selection of 2.4 mg for the combination product CagriSema
This approach accelerates drug discovery and expands therapeutic options for clinical application
